September 12, 2023 Comments Off on New patent expiration for Teva Branded drug PROAIR HFA Posted in: Uncategorized
Annual Drug Patent Expirations for PROAIR+HFA Proair Hfa is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from five suppliers. There are…
The post New patent expiration for Teva Branded drug PROAIR HFA appeared first…
September 12, 2023 Comments Off on Drug Patent Expirations for the Week of September 10, 2023 Posted in: Uncategorized
TYZEKA (telbivudine) Novartis Patent: 7,589,079 Expiration: Sep 11, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Pat…
